Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

USA - NASDAQ:ADUS - US0067391062 - Common Stock

118.31 USD
+1.18 (+1.01%)
Last: 10/17/2025, 8:00:00 PM
118.31 USD
0 (0%)
After Hours: 10/17/2025, 8:00:00 PM
Fundamental Rating

6

Overall ADUS gets a fundamental rating of 6 out of 10. We evaluated ADUS against 101 industry peers in the Health Care Providers & Services industry. ADUS scores excellent on profitability, but there are some minor concerns on its financial health. ADUS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
In the past year ADUS had a positive cash flow from operations.
Each year in the past 5 years ADUS has been profitable.
Each year in the past 5 years ADUS had a positive operating cash flow.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

ADUS has a better Return On Assets (5.89%) than 81.19% of its industry peers.
Looking at the Return On Equity, with a value of 8.12%, ADUS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
ADUS has a Return On Invested Capital of 6.98%. This is in the better half of the industry: ADUS outperforms 69.31% of its industry peers.
ADUS had an Average Return On Invested Capital over the past 3 years of 7.23%. This is below the industry average of 9.33%.
Industry RankSector Rank
ROA 5.89%
ROE 8.12%
ROIC 6.98%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of ADUS (6.51%) is better than 83.17% of its industry peers.
ADUS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.13%, ADUS is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
ADUS's Operating Margin has improved in the last couple of years.
The Gross Margin of ADUS (32.59%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ADUS has grown nicely.
Industry RankSector Rank
OM 9.13%
PM (TTM) 6.51%
GM 32.59%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADUS is destroying value.
ADUS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ADUS has more shares outstanding
ADUS has a worse debt/assets ratio than last year.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 5.06 indicates that ADUS is not in any danger for bankruptcy at the moment.
ADUS has a better Altman-Z score (5.06) than 84.16% of its industry peers.
The Debt to FCF ratio of ADUS is 1.81, which is an excellent value as it means it would take ADUS, only 1.81 years of fcf income to pay off all of its debts.
ADUS has a better Debt to FCF ratio (1.81) than 85.15% of its industry peers.
ADUS has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ADUS has a Debt to Equity ratio of 0.17. This is in the better half of the industry: ADUS outperforms 71.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.81
Altman-Z 5.06
ROIC/WACC0.82
WACC8.46%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.74, ADUS is doing good in the industry, outperforming 63.37% of the companies in the same industry.
A Quick Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS has a Quick ratio of 1.74. This is in the better half of the industry: ADUS outperforms 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.13% over the past year.
ADUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.61% yearly.
Looking at the last year, ADUS shows a quite strong growth in Revenue. The Revenue has grown by 14.29% in the last year.
Measured over the past years, ADUS shows a quite strong growth in Revenue. The Revenue has been growing by 12.22% on average per year.
EPS 1Y (TTM)11.13%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%10.37%
Revenue 1Y (TTM)14.29%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%21.79%

3.2 Future

The Earnings Per Share is expected to grow by 10.72% on average over the next years. This is quite good.
ADUS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y18.34%
EPS Next 2Y14.56%
EPS Next 3Y13.16%
EPS Next 5Y10.72%
Revenue Next Year22.44%
Revenue Next 2Y14.26%
Revenue Next 3Y11.16%
Revenue Next 5Y8.83%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.16, the valuation of ADUS can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 67.33% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ADUS to the average of the S&P500 Index (27.40), we can say ADUS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 17.20, the valuation of ADUS can be described as rather expensive.
72.28% of the companies in the same industry are more expensive than ADUS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ADUS to the average of the S&P500 Index (22.94), we can say ADUS is valued slightly cheaper.
Industry RankSector Rank
PE 21.16
Fwd PE 17.2
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ADUS is valued a bit cheaper than 60.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.26
EV/EBITDA 17.25
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ADUS may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)1.15
PEG (5Y)1.27
EPS Next 2Y14.56%
EPS Next 3Y13.16%

0

5. Dividend

5.1 Amount

No dividends for ADUS!.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (10/17/2025, 8:00:00 PM)

After market: 118.31 0 (0%)

118.31

+1.18 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners104.58%
Inst Owner Change-0.29%
Ins Owners2.4%
Ins Owner Change0.23%
Market Cap2.18B
Analysts84.44
Price Target144.75 (22.35%)
Short Float %3.47%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.93%
Min EPS beat(2)-0.58%
Max EPS beat(2)4.43%
EPS beat(4)2
Avg EPS beat(4)0.91%
Min EPS beat(4)-0.68%
Max EPS beat(4)4.43%
EPS beat(8)6
Avg EPS beat(8)4.5%
EPS beat(12)10
Avg EPS beat(12)5.23%
EPS beat(16)12
Avg EPS beat(16)4.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-1.14%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.3%
Revenue beat(12)0
Avg Revenue beat(12)-1.38%
Revenue beat(16)0
Avg Revenue beat(16)-1.87%
PT rev (1m)0%
PT rev (3m)4%
EPS NQ rev (1m)0.2%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0.3%
EPS NY rev (3m)-0.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.84%
Valuation
Industry RankSector Rank
PE 21.16
Fwd PE 17.2
P/S 1.71
P/FCF 23.26
P/OCF 21.69
P/B 2.13
P/tB N/A
EV/EBITDA 17.25
EPS(TTM)5.59
EY4.72%
EPS(NY)6.88
Fwd EY5.81%
FCF(TTM)5.09
FCFY4.3%
OCF(TTM)5.45
OCFY4.61%
SpS69.21
BVpS55.51
TBVpS-2.91
PEG (NY)1.15
PEG (5Y)1.27
Profitability
Industry RankSector Rank
ROA 5.89%
ROE 8.12%
ROCE 9.25%
ROIC 6.98%
ROICexc 7.52%
ROICexgc 96.54%
OM 9.13%
PM (TTM) 6.51%
GM 32.59%
FCFM 7.35%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.81
Debt/EBITDA 1.29
Cap/Depr 46.6%
Cap/Sales 0.53%
Interest Coverage 12.85
Cash Conversion 76.79%
Profit Quality 112.88%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 5.06
F-Score4
WACC8.46%
ROIC/WACC0.82
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)11.13%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%10.37%
EPS Next Y18.34%
EPS Next 2Y14.56%
EPS Next 3Y13.16%
EPS Next 5Y10.72%
Revenue 1Y (TTM)14.29%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%21.79%
Revenue Next Year22.44%
Revenue Next 2Y14.26%
Revenue Next 3Y11.16%
Revenue Next 5Y8.83%
EBIT growth 1Y15.88%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year45.09%
EBIT Next 3Y18.3%
EBIT Next 5Y14.43%
FCF growth 1Y-0.88%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-2.52%
OCF growth 3Y43.4%
OCF growth 5Y57.54%